CID 121304331

Schembl17712633

Structural Information

Molecular Formula
C25H31F2N5O2
SMILES
CCC1=CN=C(N=C1)N2CCC(CC2)CCCOC3=CC(=C(C(=C3)F)C4=NOC(=N4)C(C)C)F
InChI
InChI=1S/C25H31F2N5O2/c1-4-17-14-28-25(29-15-17)32-9-7-18(8-10-32)6-5-11-33-19-12-20(26)22(21(27)13-19)23-30-24(16(2)3)34-31-23/h12-16,18H,4-11H2,1-3H3
InChIKey
XQSZLXRXPGLHLH-UHFFFAOYSA-N
Compound name
3-[4-[3-[1-(5-ethylpyrimidin-2-yl)piperidin-4-yl]propoxy]-2,6-difluorophenyl]-5-propan-2-yl-1,2,4-oxadiazole
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

3
References

55
Patents

471.24457 Da
Monoisotopic Mass

5.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 472.25185 219.2
[M+Na]+ 494.23379 225.4
[M-H]- 470.23729 222.9
[M+NH4]+ 489.27839 220.3
[M+K]+ 510.20773 218.6
[M+H-H2O]+ 454.24183 203.3
[M+HCOO]- 516.24277 227.9
[M+CH3COO]- 530.25842 224.4
[M+Na-2H]- 492.21924 213.2
[M]+ 471.24402 218.6
[M]- 471.24512 218.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe